|
US2616927A
(en)
|
1950-05-12 |
1952-11-04 |
Minnesota Mining & Mfg |
Fluorocarbon tertiary amines
|
|
JPS5721312A
(en)
|
1980-07-12 |
1982-02-04 |
Green Cross Corp:The |
Breathable ointment
|
|
US4452818A
(en)
|
1982-03-19 |
1984-06-05 |
Haidt Sterling J |
Extraocular method of treating the eye with liquid perfluorocarbons
|
|
US4649047A
(en)
|
1985-03-19 |
1987-03-10 |
University Of Georgia Research Foundation, Inc. |
Ophthalmic treatment by topical administration of cyclosporin
|
|
US5077036A
(en)
|
1986-01-14 |
1991-12-31 |
Alliance Pharmaceutical Corp. |
Biocompatible stable fluorocarbon emulsions for contrast enhancement and oxygen transport comprising 40-125% wt./volume fluorocarbon combined with a phospholipid
|
|
JPH0764702B2
(ja)
|
1986-04-23 |
1995-07-12 |
鐘紡株式会社 |
多相乳化型化粧料
|
|
JPS6452722A
(en)
|
1987-05-01 |
1989-02-28 |
Anjierini Pharmaceut Inc |
Ophthalmic composition
|
|
JPH03279323A
(ja)
|
1989-12-15 |
1991-12-10 |
Johnson & Johnson Consumer Prod Inc |
日焼け止め組成物
|
|
JP3046346B2
(ja)
|
1990-03-12 |
2000-05-29 |
昭和電工株式会社 |
外用剤基剤又は補助剤とそれを含有する人又は動物の外用剤
|
|
US5518731A
(en)
|
1990-09-27 |
1996-05-21 |
Allergan, Inc. |
Nonaqueous fluorinated drug delivery vehicle suspensions
|
|
US6458376B1
(en)
|
1990-09-27 |
2002-10-01 |
Allergan, Inc. |
Nonaqueous fluorinated drug delivery suspensions
|
|
US5152997A
(en)
|
1990-12-11 |
1992-10-06 |
Theratech, Inc. |
Method and device for transdermally administering testosterone across nonscrotal skin at therapeutically effective levels
|
|
US5326566A
(en)
|
1991-05-17 |
1994-07-05 |
Bristol-Myers Squibb Company |
Use of dibutyl adipate and isopropyl myristate in topical and transdermal products
|
|
GB9114374D0
(en)
|
1991-07-03 |
1991-08-21 |
Smithkline Beecham Plc |
Novel process
|
|
US5126127A
(en)
|
1991-07-16 |
1992-06-30 |
Euroceltique, S.A. |
Stabilized PVP-I solutions
|
|
FR2679150A1
(fr)
|
1991-07-17 |
1993-01-22 |
Atta |
Preparations comprenant un fluorocarbure ou compose hautement fluore et un compose organique lipophile-fluorophile, et leurs utilisations.
|
|
US6602900B2
(en)
|
1992-09-21 |
2003-08-05 |
Allergan, Inc. |
Cyclopentane heptan(ENE)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
|
|
US5336175A
(en)
|
1992-10-29 |
1994-08-09 |
Mames Robert N |
Method for the treatment of retinal detachments
|
|
US5370313A
(en)
|
1994-01-10 |
1994-12-06 |
Beard; Walter C. |
Sterile liquid dispenser
|
|
DE4405627A1
(de)
|
1994-02-22 |
1995-08-24 |
Hoechst Ag |
Fluorkohlenwasserstoffe enthaltende Ölemulsionen
|
|
FR2720943B1
(fr)
|
1994-06-09 |
1996-08-23 |
Applic Transferts Technolo |
Emulsions inverses stables à forte concentration en composé(s) fluoré(s) et leur utilisation pour l'administration pulmonaire de médicaments et pour la fabrication d'émulsions multiples.
|
|
US5849291A
(en)
|
1994-10-17 |
1998-12-15 |
Symbollon Corporation |
Opthalmic non-irritating iodine medicament
|
|
US6294563B1
(en)
|
1994-10-27 |
2001-09-25 |
Allergan Sales, Inc. |
Combinations of prostaglandins and brimonidine or derivatives thereof
|
|
US5696164A
(en)
|
1994-12-22 |
1997-12-09 |
Johnson & Johnson Consumer Products, Inc. |
Antifungal treatment of nails
|
|
US5874481A
(en)
|
1995-06-07 |
1999-02-23 |
Alliance Pharmaceutical Corp. |
Fluorochemical solutions for the delivery of lipophilic pharmaceutical agents
|
|
US5667809A
(en)
|
1995-06-07 |
1997-09-16 |
Alliance Pharmaceutical Corp. |
Continuous fluorochemical microdispersions for the delivery of lipophilic pharmaceutical agents
|
|
US5578020A
(en)
|
1995-09-01 |
1996-11-26 |
Mosley; Manuel L. |
Drop dispensing apparatus
|
|
DE19536504C2
(de)
|
1995-09-29 |
1999-09-23 |
H Meinert |
Verwendung fluorierter Alkane
|
|
US5874469A
(en)
|
1996-01-05 |
1999-02-23 |
Alcon Laboratories, Inc. |
Fluoroalkyl hydrocarbons for administering water insoluble or unstable drugs
|
|
RU2111738C1
(ru)
|
1996-06-24 |
1998-05-27 |
Акционерное общество "НИЗАР" |
Средство для усиления солнцезащитной активности фотозащитных агентов
|
|
FR2752161B1
(fr)
|
1996-08-07 |
1998-09-25 |
Atta |
Emulsions multiples de type hydrocarbure-dans-eau-dans- fluorocarbone pour le transport de substances medicamenteuses hydrophiles et/ou lipophiles
|
|
US5863560A
(en)
|
1996-09-11 |
1999-01-26 |
Virotex Corporation |
Compositions and methods for topical application of therapeutic agents
|
|
IN184589B
(OSRAM)
|
1996-10-16 |
2000-09-09 |
Alza Corp |
|
|
DE69823852T2
(de)
|
1997-02-04 |
2005-05-19 |
Johnstone, Murray A., Seattle |
Verfahren zur förderung des haarwuchses und entwicklung des haarsystems
|
|
DE19709704C2
(de)
|
1997-03-10 |
1999-11-04 |
Michael Georgieff |
Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie
|
|
US5980936A
(en)
|
1997-08-07 |
1999-11-09 |
Alliance Pharmaceutical Corp. |
Multiple emulsions comprising a hydrophobic continuous phase
|
|
US6335335B2
(en)
|
1997-11-05 |
2002-01-01 |
Senju Pharmaceutical Co., Ltd. |
Prolonged-action eye drop
|
|
US5851544A
(en)
|
1997-12-18 |
1998-12-22 |
Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. |
Cosmetic skin or hair care compositions containing fluorocarbons infused with carbon dioxide
|
|
US5981607A
(en)
|
1998-01-20 |
1999-11-09 |
Allergan |
Emulsion eye drop for alleviation of dry eye related symptoms in dry eye patients and/or contact lens wearers
|
|
PT983037E
(pt)
|
1998-02-09 |
2003-09-30 |
Macrochem Corp |
Verniz para unhas antifungico
|
|
DE19861012A1
(de)
|
1998-03-18 |
1999-09-30 |
Pharm Pur Gmbh |
Behandlungsmittel für die Ophthalmologie
|
|
ES2211151T3
(es)
|
1998-08-19 |
2004-07-01 |
Skyepharma Canada Inc. |
Dispersiones acuosas inyectables de propofol.
|
|
US6140374A
(en)
|
1998-10-23 |
2000-10-31 |
Abbott Laboratories |
Propofol composition
|
|
US6159977A
(en)
|
1998-11-16 |
2000-12-12 |
Astan, Inc. |
Therapeutic anti-fungal nail preparation
|
|
JP4861551B2
(ja)
|
1999-02-08 |
2012-01-25 |
インターシア セラピューティクス，インコーポレイティド |
安定な非水性単相粘性ビヒクルおよびそのようなビヒクルを使用する配合物
|
|
US7258869B1
(en)
|
1999-02-08 |
2007-08-21 |
Alza Corporation |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
|
|
EP1124416A1
(en)
|
1999-03-15 |
2001-08-22 |
John Claude Krusz |
Treatment of acute headaches and chronic pain using rapidly-cleared anesthetic drug at sub-anesthetic dosages
|
|
US6177477B1
(en)
|
1999-03-24 |
2001-01-23 |
American Home Products Corporation |
Propofol formulation containing TRIS
|
|
US6239113B1
(en)
|
1999-03-31 |
2001-05-29 |
Insite Vision, Incorporated |
Topical treatment or prevention of ocular infections
|
|
DE19926890C1
(de)
|
1999-06-12 |
2000-07-27 |
Pharm Pur Gmbh |
Verwendung eines hochfluorierten oligomeren Alkans in der Ophthalmologie
|
|
DE19938668B4
(de)
|
1999-08-14 |
2006-01-26 |
Bausch & Lomb Inc. |
Tränenersatzmittel
|
|
US6528086B2
(en)
|
1999-09-28 |
2003-03-04 |
Zars, Inc. |
Methods and apparatus for drug delivery involving phase changing formulations
|
|
JP2001158734A
(ja)
|
1999-12-02 |
2001-06-12 |
Lion Corp |
眼科用組成物及びソフトコンタクトレンズに対する吸着抑制方法
|
|
US6576663B2
(en)
|
1999-12-22 |
2003-06-10 |
Alcon, Inc. |
6-Keto prostaglandin F1α and analogs for treating dry eye
|
|
US20030018044A1
(en)
|
2000-02-18 |
2003-01-23 |
Peyman Gholam A. |
Treatment of ocular disease
|
|
DE10024413A1
(de)
|
2000-05-19 |
2001-12-06 |
Mika Pharma Gmbh |
Pharmazeutische und/oder kosmetische Zubereitung
|
|
DE10042412B4
(de)
|
2000-08-30 |
2005-12-22 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales therapeutisches System zur Abgabe von Venlafaxin, und seine Verwendung
|
|
US6399087B1
(en)
|
2000-12-20 |
2002-06-04 |
Amphastar Pharmaceuticals, Inc. |
Propofol formulation with enhanced microbial inhibition
|
|
US20030027833A1
(en)
|
2001-05-07 |
2003-02-06 |
Cleary Gary W. |
Compositions and delivery systems for administration of a local anesthetic agent
|
|
TWI298257B
(en)
|
2001-05-31 |
2008-07-01 |
Allergan Inc |
Hypotensive lipid and timolol compositions and methods of using same
|
|
KR100757611B1
(ko)
|
2001-09-04 |
2007-09-10 |
트롬스도르프 게엠베하 운트 코. 카게 알츠나이미텔 |
손발톱 성장의 기능장애와 질환을 치료하기 위한 플라스터
|
|
AU2003206183A1
(en)
|
2002-01-26 |
2003-09-02 |
Micro Science Tech Co., Ltd |
Composition containing moutan root bark extract as active ingredient
|
|
CA2481394A1
(en)
|
2002-05-24 |
2003-12-04 |
Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh |
Drop-forming ophthalmic gel preparation comprising diclofenamide and timolol
|
|
US20040033228A1
(en)
|
2002-08-16 |
2004-02-19 |
Hans-Juergen Krause |
Formulation of human antibodies for treating TNF-alpha associated disorders
|
|
US7074827B2
(en)
|
2002-10-24 |
2006-07-11 |
Sucampo Ag (Usa) Inc. |
Method for treating ocular hypertension and glaucoma
|
|
JP3998596B2
(ja)
|
2003-03-31 |
2007-10-31 |
日本ペイント株式会社 |
塗膜ムラの算出式算出方法及び塗膜ムラの数値化方法
|
|
BRPI0412975A
(pt)
|
2003-08-25 |
2006-10-03 |
Foamix Ltd |
espuma penetrante para uso farmacêutico
|
|
US20050079210A1
(en)
|
2003-10-09 |
2005-04-14 |
Gupta Shyam K. |
Liposomal delivery system for topical pharmaceutical, cosmeceutical, and cosmetic ingredients
|
|
ATE534373T1
(de)
|
2003-10-10 |
2011-12-15 |
Antares Pharma Ipl Ag |
Transdermale pharmazeutische formulierung zur minimierung von rückständen auf der haut
|
|
AU2004293027A1
(en)
|
2003-11-19 |
2005-06-09 |
Barnes-Jewish Hospital |
Enhanced drug delivery
|
|
GB0408164D0
(en)
|
2004-04-13 |
2004-05-19 |
Immune Targeting Systems Ltd |
Antigen delivery vectors and constructs
|
|
CA2563544A1
(en)
|
2004-04-19 |
2005-10-27 |
Centre National De La Recherche Scientifique (C.N.R.S.) |
Lung surfactant supplements
|
|
WO2005112667A1
(ja)
*
|
2004-05-20 |
2005-12-01 |
Takashi Omori |
健康食品
|
|
US20050288197A1
(en)
|
2004-06-08 |
2005-12-29 |
Ocularis Pharma, Inc. |
Silicone polymer topical eye compositions and methods of use
|
|
US7063241B2
(en)
|
2004-06-10 |
2006-06-20 |
Allergan, Inc. |
Dispensing tip
|
|
CN101043884A
(zh)
|
2004-07-01 |
2007-09-26 |
谢彭斯眼科研究公司 |
用于治疗眼部疾病和病症的组合物和方法
|
|
US20060078580A1
(en)
|
2004-10-08 |
2006-04-13 |
Mediquest Therapeutics, Inc. |
Organo-gel formulations for therapeutic applications
|
|
US7740875B2
(en)
|
2004-10-08 |
2010-06-22 |
Mediquest Therapeutics, Inc. |
Organo-gel formulations for therapeutic applications
|
|
EP1688161A1
(en)
|
2004-11-02 |
2006-08-09 |
Switch Biotech Aktiengesellschaft |
Use of pirlindole for the treatment of diseases which are characterized by proliferation of t-lymphocytes and/or hyperproliferation of keratinocytes in particular atopic dermatitis and psoriasis
|
|
US7851504B2
(en)
|
2005-03-16 |
2010-12-14 |
Allergan, Inc. |
Enhanced bimatoprost ophthalmic solution
|
|
GB0511499D0
(en)
|
2005-06-06 |
2005-07-13 |
Medpharm Ltd |
Topical ungual formulations
|
|
WO2007008666A2
(en)
|
2005-07-08 |
2007-01-18 |
Ocularis Pharma, Inc. |
Compositions and methods for improving vision using adherent thin films
|
|
JP2009503059A
(ja)
|
2005-08-05 |
2009-01-29 |
ブハラット セルムズ アンド ヴァクシンズ リミテッド |
防腐効果を有する静脈プロポフォールエマルジョン組成物
|
|
FR2892023B1
(fr)
|
2005-10-14 |
2009-09-25 |
Galderma Sa |
Composition pharmaceutique a base d'amorolfine et d'agent filmogene hydrosoluble pour application ungueale et peri-ungueale
|
|
DE102005050431A1
(de)
|
2005-10-21 |
2007-04-26 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales therapeutisches System zur Verabreicherung lipophiler und/oder wenig hautpermeabler Wirkstoffe
|
|
DE102005055811A1
(de)
*
|
2005-11-23 |
2007-05-31 |
Novaliq Gmbh |
Verwendung einer Zusammensetzung zur Konservierung von Organen und Gliedmaßen
|
|
TWI376239B
(en)
|
2006-02-01 |
2012-11-11 |
Andrew Xian Chen |
Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
|
|
US20070238732A1
(en)
|
2006-04-10 |
2007-10-11 |
Allergan, Inc. |
Brimonidine and timolol compositions
|
|
US7608261B2
(en)
|
2006-06-16 |
2009-10-27 |
Regeneron Pharmacuticals, Inc. |
VEGF antagonist formulations suitable for intravitreal administration
|
|
KR20090053892A
(ko)
|
2006-07-25 |
2009-05-28 |
오스모티카 코프. |
점안액
|
|
US20080112895A1
(en)
|
2006-08-04 |
2008-05-15 |
Insys Therapeutics Inc. |
Aqueous dronabinol formulations
|
|
US20080039807A1
(en)
|
2006-08-08 |
2008-02-14 |
Jerrold Scott Pine |
Ophthalmic Drug Dispensing Tip
|
|
US20080089923A1
(en)
|
2006-09-29 |
2008-04-17 |
Burkstrand Michael J |
Biodegradable ocular implants and methods for treating ocular conditions
|
|
US9000048B2
(en)
|
2006-11-28 |
2015-04-07 |
Wisconsin Alumni Research Foundation |
Fluoropolymer-based emulsions for the intravenous delivery of fluorinated volatile anesthetics
|
|
AU2007330356B2
(en)
|
2006-12-07 |
2013-05-02 |
Sun Pharma Advanced Research Company Ltd |
Metered drop bottle for dispensing microliter amounts of a liquid in the form of a drop
|
|
CN200977281Y
(zh)
|
2006-12-08 |
2007-11-21 |
陈宇 |
带助滴器的滴眼瓶
|
|
US7959293B2
(en)
*
|
2007-05-04 |
2011-06-14 |
Abbott Medical Optics Inc. |
Methods and devices for measuring tear film and diagnosing tear disorders
|
|
ITMI20070890A1
(it)
|
2007-05-04 |
2008-11-05 |
Sifi Spa |
Composizioni oftalmiche per il trattamento della ipertensione oculare e del glaucoma
|
|
WO2008157614A2
(en)
|
2007-06-21 |
2008-12-24 |
Yale University |
Sustained intraocular delivery of drugs from biodegradable polymeric microparticles
|
|
FR2918891B1
(fr)
|
2007-07-20 |
2009-09-25 |
Thea Sa Lab |
Solution ophtalmique a base de prostaglandines sans conservateur
|
|
US8222292B2
(en)
|
2007-08-06 |
2012-07-17 |
Insys Therapeutics, Inc. |
Liquid cannabinoid formulations
|
|
DE102007055046A1
(de)
|
2007-11-19 |
2009-05-28 |
Fluoron Gmbh |
Infusionslösung
|
|
US20090136430A1
(en)
|
2007-11-27 |
2009-05-28 |
Dugger Harry A |
Antihistamine/Corticosteroid preparations for the treatment of atopic dermatitis
|
|
WO2009072007A2
(en)
|
2007-12-07 |
2009-06-11 |
Foamix Ltd. |
Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
|
|
EP2242504B1
(en)
|
2008-01-09 |
2021-07-14 |
The Schepens Eye Research Institute, Inc. |
Therapeutic compositions for treatment of ocular inflammatory disorders
|
|
ATE532505T1
(de)
|
2008-04-18 |
2011-11-15 |
Novaliq Gmbh |
Inhalative und instillative verwendung von semifluorierten alkanen als wirkstoffträger im intrapulmonalen bereich
|
|
US20100006600A1
(en)
|
2008-07-14 |
2010-01-14 |
Dascanio Gustavo A |
Fluid dispenser including hydrophobic ring
|
|
HUE032158T2
(en)
|
2008-10-31 |
2017-09-28 |
Univ Mississippi |
Process for the preparation of delta9-THC amino acid esters
|
|
CA2743824A1
(en)
|
2008-11-26 |
2010-06-03 |
Surmodics, Inc. |
Implantable ocular drug delivery device and methods
|
|
US8669241B2
(en)
|
2008-12-02 |
2014-03-11 |
Rohto Pharmaceutical Co., Ltd. |
Ophthalmic composition
|
|
US8501800B2
(en)
|
2009-03-05 |
2013-08-06 |
Insite Vision Incorporated |
Controlled-release ophthalmic vehicles
|
|
IT1393419B1
(it)
|
2009-03-19 |
2012-04-20 |
Medivis S R L |
Composizioni oftalmiche a base di acidi grassi polinsaturi omega-3 e omega-6.
|
|
US9062275B2
(en)
|
2009-04-17 |
2015-06-23 |
Natac Pharma, S.L. |
Compositions rich in omega-3 fatty acids with a low content in phytanic acid
|
|
WO2010146536A1
(en)
|
2009-06-18 |
2010-12-23 |
Koninklijke Philips Electronics N.V. |
Suspension of particles with drug
|
|
JP5736635B2
(ja)
|
2009-06-25 |
2015-06-17 |
ライオン株式会社 |
ドライアイ治療剤
|
|
CN102802619A
(zh)
|
2009-06-25 |
2012-11-28 |
狮王株式会社 |
眼科用组合物
|
|
PT2387391T
(pt)
|
2009-07-24 |
2017-04-20 |
Mika Pharma Ges Für Die Entw Und Vermarktung Pharmazeutischer Produkte Mbh |
Processo para o desenvolvimento de uma composição líquida a ser aplicada na forma de espuma sobre a pele e composição de aplicação tópica
|
|
JP2011024841A
(ja)
|
2009-07-28 |
2011-02-10 |
健太 ▲浜崎▼ |
点眼補助具
|
|
AT509000B1
(de)
|
2009-10-23 |
2012-12-15 |
Rausch Peter |
Wasserlösliche zubereitungen von cannabinoiden und cannabispräparaten und deren anwendungen
|
|
US9149484B2
(en)
|
2009-11-09 |
2015-10-06 |
Allergan, Inc. |
Compositions and methods for stimulating hair growth
|
|
EP2332525A1
(en)
|
2009-11-23 |
2011-06-15 |
Novaliq GmbH |
Pharmaceutical composition comprising propofol
|
|
EP2335735A1
(en)
*
|
2009-12-14 |
2011-06-22 |
Novaliq GmbH |
Pharmaceutical composition for treatment of dry eye syndrome
|
|
US20110223208A1
(en)
|
2010-03-09 |
2011-09-15 |
Beth Hill |
Non-Aqueous High Concentration Reduced Viscosity Suspension Formulations
|
|
IN2012DN06581A
(OSRAM)
|
2010-03-17 |
2015-10-23 |
Novaliq Gmbh |
|
|
DE102010022567A1
(de)
*
|
2010-06-02 |
2011-12-08 |
Fluoron Gmbh |
Zubereitung
|
|
HUP1000362A2
(en)
|
2010-07-12 |
2012-11-28 |
Egis Gyogyszergyar Nyrt |
Antiseptic and disinfecting compositions having reduced iodine content
|
|
EP2444063A1
(en)
|
2010-10-20 |
2012-04-25 |
Novaliq GmbH |
Liquid pharmaceutical compositions for the delivery of active ingredients
|
|
US20120100183A1
(en)
|
2010-10-23 |
2012-04-26 |
Joel Schlessinger |
Topical base and active agent-containing compositions, and methods for improving and treating skin
|
|
EP2445266B1
(en)
*
|
2010-10-25 |
2016-03-16 |
Alcatel Lucent |
Control of access network/access technology selection for the routing of IP traffic by a user equipment, and QoS support, in a multi-access communication system
|
|
EP2462921A1
(en)
|
2010-11-11 |
2012-06-13 |
Novaliq GmbH |
Liquid pharmaceutical compositions for the treatment of a posterior eye disease
|
|
BR112013016661B1
(pt)
|
2011-01-04 |
2021-08-03 |
Novaliq Gmbh |
Emulsões de o/a compreendendo alcanos semifluorados
|
|
CA2824422A1
(en)
|
2011-01-13 |
2012-07-19 |
Regeneron Pharmaceuticals, Inc. |
Use of a vegf antagonist to treat angiogenic eye disorders
|
|
US20120219640A1
(en)
|
2011-02-25 |
2012-08-30 |
Wright Kenneth W |
Anti-infective solution for athlete's foot
|
|
KR101773648B1
(ko)
|
2011-05-25 |
2017-08-31 |
노바리크 게엠베하 |
조갑에 투여를 위한 제약학적 조성물
|
|
JP6039145B2
(ja)
|
2011-05-25 |
2016-12-07 |
ノバリック ゲーエムベーハー |
半フッ化アルカンを基礎にした局所薬学的組成物
|
|
CN202136470U
(zh)
|
2011-06-08 |
2012-02-08 |
天津市金亿达药用包装材料有限公司 |
便于滴药的眼药瓶
|
|
US8758826B2
(en)
|
2011-07-05 |
2014-06-24 |
Wet Inc. |
Cannabinoid receptor binding agents, compositions, and methods
|
|
AU2013208002B2
(en)
|
2012-01-10 |
2017-11-30 |
Allergan, Inc. |
Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
|
|
PT2806886T
(pt)
|
2012-01-23 |
2017-03-24 |
Novaliq Gmbh |
Composições de proteínas estabilizadas baseadas em alcanos semifluorados
|
|
US9549966B2
(en)
|
2012-02-21 |
2017-01-24 |
Massachusetts Eye & Ear Infirmary |
Inflammatory eye disorders
|
|
NZ701915A
(en)
|
2012-05-18 |
2016-11-25 |
Genentech Inc |
High-concentration monoclonal antibody formulations
|
|
US9878000B2
(en)
|
2012-06-20 |
2018-01-30 |
University Of Waterloo |
Mucoadhesive nanoparticle composition comprising immunosuppresant and methods of use thereof
|
|
HK1204992A1
(en)
|
2012-06-25 |
2015-12-11 |
Bayer Healthcare Llc |
Topical ophthalmological pharmaceutical composition containing sunitinib
|
|
TR201812013T4
(tr)
*
|
2012-09-12 |
2018-09-21 |
Novaliq Gmbh |
Göz yikama bi̇leşi̇mleri̇.
|
|
EP3181119B1
(en)
*
|
2012-09-12 |
2019-07-10 |
Novaliq GmbH |
Semifluorinated alkane compositions for use in the treatment of keratoconjunctivitis sicca
|
|
CN113952321B
(zh)
|
2012-09-12 |
2023-03-28 |
诺瓦利克有限责任公司 |
包含半氟化烷烃的混合物的组合物
|
|
EP2730291A1
(en)
|
2012-11-09 |
2014-05-14 |
Fluoron Gmbh |
Internal Tamponade Composition
|
|
US10349069B2
(en)
*
|
2012-12-11 |
2019-07-09 |
Sony Interactive Entertainment Inc. |
Software hardware hybrid video encoder
|
|
TW201427989A
(zh)
|
2012-12-18 |
2014-07-16 |
Novartis Ag |
長效性蛋白質之組合物及方法
|
|
PT2968650T
(pt)
|
2013-03-14 |
2019-02-12 |
Panoptica Inc |
Formulações oculares para administração de fármacos ao segmento posterior do olho
|
|
EP2783703A1
(en)
|
2013-03-25 |
2014-10-01 |
B. Braun Melsungen AG |
Semifluorocarbon compound containing contrast agent
|
|
PT3024484T
(pt)
|
2013-07-23 |
2018-10-24 |
Novaliq Gmbh |
Composições de anticorpo estabilizadas
|
|
US9265809B2
(en)
|
2013-10-09 |
2016-02-23 |
Johnson Living Trust dated October 26, 2011, Leonidas A. Johnson, Trustee |
Methods and compositions for treating and preventing signs or symptoms of eye disease
|
|
CN203524843U
(zh)
|
2013-10-20 |
2014-04-09 |
吕相瑜 |
自助滴眼液辅助支架
|
|
CA2931039C
(en)
|
2013-11-20 |
2022-07-12 |
Mary Lynch |
Compositions and methods for treatment of ocular inflammation and pain
|
|
FR3013977A1
(fr)
|
2013-12-03 |
2015-06-05 |
Oreal |
Composition cosmetique comprenant des filtres uv
|
|
CA2943255C
(en)
|
2014-03-31 |
2023-01-24 |
Amcor Limited |
Controlled release container
|
|
EP2944324A1
(de)
*
|
2014-05-13 |
2015-11-18 |
LTS LOHMANN Therapie-Systeme AG |
Verwendung von semifluorierten Alkanen in transdermalen therapeutischen Systemen
|
|
US9186305B1
(en)
|
2014-05-19 |
2015-11-17 |
Shiseido Company, Ltd. |
Sunscreen products in which excessive whiteness due to titanium dioxide and zinc oxide is visually masked upon skin application
|
|
CN106572941B
(zh)
|
2014-08-13 |
2020-06-23 |
佛罗里达大学研究基金会股份有限公司 |
从眼药水中去除防腐剂
|
|
UA124698C2
(uk)
|
2014-10-20 |
2021-11-03 |
Сентіс Фарма Прайвет Лімітед |
Офтальмологічний розчин
|
|
WO2016082644A1
(en)
|
2014-11-26 |
2016-06-02 |
The University Of Hong Kong |
A semifluorinated alkane based cleaner for removing emulsified droplets in the eye to reduce the complications associated with the emulsification of silicone oil
|
|
MA41299A
(fr)
|
2014-12-30 |
2017-11-07 |
Axim Biotechnologies Inc |
Solutions ophtalmiques pour le traitement du glaucome et de la conjonctivite
|
|
WO2016108130A1
(en)
|
2014-12-30 |
2016-07-07 |
Sun Pharmaceutical Industries Limited |
Topical pharmaceutical compositions comprising nebivolol for the treatment of diabetic wounds
|
|
PT3356313T
(pt)
|
2015-09-30 |
2020-07-13 |
Novaliq Gmbh |
2-perfluoro-hexiloctano para administração oftálmica
|
|
CN111743882A
(zh)
|
2015-09-30 |
2020-10-09 |
诺瓦利克有限责任公司 |
半氟化化合物和其组合物
|
|
US10286035B2
(en)
|
2015-10-14 |
2019-05-14 |
Paul Gavaris |
Ophthalmic treatment composition and vehicle for delivery of pharmaceutical substances or therapeutic agents
|
|
RU2734958C2
(ru)
|
2015-11-18 |
2020-10-26 |
Формикон Аг |
Предварительно заполненная фармацевтическая упаковка, содержащая жидкий состав на основе антагониста vegf
|
|
CA3010862A1
(en)
|
2016-01-08 |
2017-07-13 |
Clearside Biomedical, Inc. |
Methods and devices for treating posterior ocular disorderswith aflibercept and other biologics
|
|
CA3021394C
(en)
|
2016-02-04 |
2021-12-28 |
Gordon Wayne Dyer |
Method for breaching an oleo and hydro resistant arthropod plastron by applying a low molecular weight non-polar chemical breacher to the plastron
|
|
CA3026053A1
(en)
|
2016-06-01 |
2017-12-07 |
Harold Richard Hellstrom |
Treatment of dry eye disease with parasympathetic and anti-sympathetic agents
|
|
CA2983765C
(en)
|
2016-06-08 |
2018-02-27 |
Majda Ficko |
Sun block formulation
|
|
CN109640900B
(zh)
|
2016-06-23 |
2020-07-07 |
诺瓦利克有限责任公司 |
一种试剂盒
|
|
CN106176937A
(zh)
|
2016-08-24 |
2016-12-07 |
刘艺鹏 |
湿疹、痤疮软膏
|
|
CN109890374A
(zh)
|
2016-09-22 |
2019-06-14 |
诺瓦利克有限责任公司 |
用于治疗睑缘炎的药物组合物
|
|
US10813976B2
(en)
|
2016-09-23 |
2020-10-27 |
Novaliq Gmbh |
Ophthalmic compositions comprising ciclosporin
|
|
EP3518921B1
(en)
|
2016-09-28 |
2021-08-11 |
Novaliq GmbH |
Compositions comprising a cannabinoid receptor binding ligand
|
|
JP7116059B2
(ja)
|
2016-11-21 |
2022-08-09 |
ジャスト－エヴォテック バイオロジックス、インコーポレイテッド |
アフリベルセプト製剤及びその使用
|
|
EP3558308A1
(en)
|
2016-12-22 |
2019-10-30 |
Novaliq GmbH |
Compositions comprising tacrolimus for the treatment of intraocular inflammatory eye diseases
|
|
KR102288022B1
(ko)
|
2016-12-23 |
2021-08-10 |
노바리크 게엠베하 |
건성 안 질환 치료용 안구 조성물
|
|
MX388460B
(es)
|
2017-04-21 |
2025-03-20 |
Dermaliq Therapeutics Inc |
Composiciones de yodo.
|
|
US20210069014A1
(en)
|
2017-05-06 |
2021-03-11 |
Novaliq Gmbh |
Drop dispenser
|
|
CN110650734B
(zh)
|
2017-05-12 |
2024-11-15 |
诺瓦利克有限责任公司 |
治疗与隐形眼镜有关病症的包含半氟化烷烃的药物组合物
|
|
KR20200059272A
(ko)
|
2017-09-27 |
2020-05-28 |
노바리크 게엠베하 |
안구 질환의 치료에서의 사용을 위한 라타노프로스트를 포함하는 안과적 조성물
|
|
WO2019068763A1
(en)
|
2017-10-04 |
2019-04-11 |
Novaliq Gmbh |
OPHTHALMIC COMPOSITIONS COMPRISING F6H8
|
|
CA3091308A1
(en)
|
2018-03-02 |
2019-09-06 |
Novaliq Gmbh |
Pharmaceutical compositions comprising nebivolol
|
|
CN111867560B
(zh)
|
2018-03-28 |
2024-08-13 |
诺瓦利克有限责任公司 |
包含噻吗洛尔的药物组合物
|
|
CN112153970A
(zh)
|
2018-04-27 |
2020-12-29 |
诺瓦利克有限责任公司 |
用于治疗青光眼的包含他氟前列素的眼用组合物
|
|
CA3111873A1
(en)
|
2018-09-22 |
2020-03-26 |
Novaliq Gmbh |
Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness
|
|
SG11202102820VA
(en)
|
2018-10-12 |
2021-04-29 |
Novaliq Gmbh |
Ophthalmic composition for treatment of dry eye disease
|
|
SG11202104350RA
(en)
|
2018-11-27 |
2021-05-28 |
Novaliq Gmbh |
Semifluorinated alkane compositions comprising omega-3 fatty acid ethyl esters
|
|
CN113518619A
(zh)
|
2019-01-21 |
2021-10-19 |
诺瓦利克有限责任公司 |
用于治疗眼部新生血管形成的药物组合物
|
|
CN113710228A
(zh)
|
2019-02-13 |
2021-11-26 |
诺瓦利克有限责任公司 |
用于治疗眼部新生血管形成的组合物和方法
|
|
CN114206344A
(zh)
|
2019-08-09 |
2022-03-18 |
诺瓦利克有限责任公司 |
包含前列腺素类似物的局部组合物
|
|
MX2022002667A
(es)
|
2019-09-06 |
2022-04-07 |
Novaliq Gmbh |
Composicion oftalmica para el tratamiento de uveitis.
|
|
CN115151242A
(zh)
|
2019-11-27 |
2022-10-04 |
诺瓦利克有限责任公司 |
包含悬浮在非水性媒介物中的蛋白质颗粒的悬浮液
|